Reckitt Benckiser Group (LON:RB) had its price target hoisted by Jefferies Financial Group from GBX 6,600 ($81.22) to GBX 7,100 ($87.37) in a report published on Wednesday, Stock Target Advisor reports. The brokerage currently has a hold rating on the stock.
Several other equities research analysts have also commented on RB. Deutsche Bank reiterated a buy rating and set a GBX 8,400 ($103.37) price objective on shares of Reckitt Benckiser Group in a research note on Wednesday. Berenberg Bank increased their price objective on Reckitt Benckiser Group from GBX 8,000 ($98.45) to GBX 9,000 ($110.76) and gave the stock a buy rating in a research report on Wednesday. HSBC reiterated a buy rating and issued a GBX 8,300 ($102.14) price objective on shares of Reckitt Benckiser Group in a research report on Monday, July 20th. Goldman Sachs Group reiterated a neutral rating on shares of Reckitt Benckiser Group in a research report on Wednesday, July 1st. Finally, UBS Group reiterated a buy rating and issued a GBX 8,400 ($103.37) price objective on shares of Reckitt Benckiser Group in a research report on Monday, July 27th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and thirteen have assigned a buy rating to the stock. The stock presently has a consensus rating of Buy and a consensus price target of GBX 7,655.56 ($94.21).
LON:RB opened at GBX 7,706 ($94.83) on Wednesday. Reckitt Benckiser Group has a 12 month low of GBX 73.44 ($0.90) and a 12 month high of GBX 8,191.30 ($100.80). The stock has a 50 day moving average of GBX 7,441.20 and a two-hundred day moving average of GBX 6,629.16. The company has a current ratio of 0.56, a quick ratio of 0.40 and a debt-to-equity ratio of 130.80. The firm has a market cap of $54.80 billion and a P/E ratio of -14.83.
In other Reckitt Benckiser Group news, insider Nicandro Durante purchased 165 shares of the business’s stock in a transaction on Wednesday, May 27th. The shares were bought at an average cost of GBX 6,884 ($84.72) per share, for a total transaction of £11,358.60 ($13,978.10).
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Further Reading: What are the disadvantages of after-hours trading?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.